The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 20, Pages 5174
Publisher
MDPI AG
Online
2021-10-16
DOI
10.3390/cancers13205174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8+ T Cell Responses via CD169+ Macrophages and cDC1
- (2021) Joanna Grabowska et al. Vaccines
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
- (2021) Rong Tang et al. Frontiers in Immunology
- Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer
- (2021) Molly A. Nelson et al. CANCER AND METASTASIS REVIEWS
- Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis
- (2021) Simon Gebremeskel et al. Journal for ImmunoTherapy of Cancer
- Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients
- (2020) Junxun Ma et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-Associated Macrophages: Recent Insights and Therapies
- (2020) Jiawei Zhou et al. Frontiers in Oncology
- Vaccines adjuvanted with an NKT cell agonist induce effective T-cell responses in models of CNS lymphoma
- (2020) Carole Grasso et al. Immunotherapy
- Phase II study of α-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer
- (2020) Takahide Toyoda et al. Journal for ImmunoTherapy of Cancer
- Recent advances in CAR-T cell engineering
- (2020) Ruihao Huang et al. Journal of Hematology & Oncology
- News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors
- (2020) Ombretta Melaiu et al. SEMINARS IN CANCER BIOLOGY
- A decade of immune-checkpoint inhibitors in cancer therapy
- (2020) Caroline Robert Nature Communications
- Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
- (2020) Bassel Nazha et al. Frontiers in Oncology
- Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis
- (2020) Andras Heczey et al. NATURE MEDICINE
- Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
- (2020) Nirav N. Shah et al. NATURE MEDICINE
- Characteristics and clinical trial results of agonistic anti‑CD40 antibodies in the treatment of malignancies (Review)
- (2020) Da-Ke Li et al. Oncology Letters
- First-Line Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Landscape and Future Progress
- (2020) Zhangfeng Huang et al. Frontiers in Pharmacology
- Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer
- (2020) Ying Wang et al. Frontiers in Immunology
- Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions
- (2020) Uri Greenbaum et al. Frontiers in Oncology
- Neoadjuvant immune checkpoint inhibitors in cancer, current state of the art
- (2020) Olivia Le Saux et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Innate and Innate-Like Cells: The Future of Chimeric Antigen Receptor (CAR) Cell Therapy
- (2020) Diana Cortés-Selva et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Enhancing anti-tumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors
- (2019) K M Heinhuis et al. ANNALS OF ONCOLOGY
- Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung cancer
- (2019) Chih‐Hsi Scott Kuo et al. Thoracic Cancer
- Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis
- (2019) Alfredo Addeo et al. Frontiers in Oncology
- Nano spray dryer for vectorizing α-galactosylceramide in polymeric nanoparticles: A single step process to enhance invariant Natural Killer T lymphocyte responses
- (2019) Michelangelo Bauwelz Gonzatti et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity
- (2019) Rajkumar Noubade et al. Frontiers in Immunology
- α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
- (2019) Yingting Zhang et al. Frontiers in Immunology
- Cytotoxic Chemotherapy as an Immune Stimulus: A Molecular Perspective on Turning Up the Immunological Heat on Cancer
- (2019) James W. Opzoomer et al. Frontiers in Immunology
- NKT cells co-expressing a GD2-specific chimeric antigen receptor and IL-15 show enhanced in vivo persistence and antitumor activity against neuroblastoma
- (2019) Xin Xu et al. CLINICAL CANCER RESEARCH
- A Glycolipid Adjuvant, 7DW8-5, Enhances the Protective Immune Response to the Current Split Influenza Vaccine in Mice
- (2019) Huapeng Feng et al. Frontiers in Microbiology
- Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor
- (2019) Sourav Paul et al. Journal for ImmunoTherapy of Cancer
- Codelivery of mRNA with α-Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration
- (2019) Maria L. Guevara et al. ACS Omega
- A combination of check-point blockade and α-galactosylceramide elicits long-lasting suppressive effects on murine hepatoma cell growth in vivo
- (2019) Kazuhito Ishii et al. IMMUNOBIOLOGY
- Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function
- (2019) Hillary G. Caruso et al. JOURNAL OF NEURO-ONCOLOGY
- α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma
- (2018) Vanessa Sainz et al. Acta Biomaterialia
- Activation of NKT cells in an anti-PD-1-resistant tumor model enhances anti-tumor immunity by reinvigorating exhausted CD8 T cells
- (2018) Eun-Ah Bae et al. CANCER RESEARCH
- Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients
- (2018) Jiayi Yu et al. Journal of Hematology & Oncology
- Repeated administration of alpha-galactosylceramide ameliorates experimental lupus nephritis in mice
- (2018) Takahiro Uchida et al. Scientific Reports
- Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression
- (2018) Filippo Cortesi et al. Cell Reports
- Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells
- (2018) Yunlong Zhao et al. Cell Reports
- Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
- (2018) Kulmira Nurgali et al. Frontiers in Pharmacology
- Epigenetic induction of CD1d expression primes lung cancer cells for killing by invariant natural killer T cells
- (2018) Éilis Dockry et al. OncoImmunology
- Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in piggyBac Transposon-Engineered T Cells
- (2018) Daisuke Morita et al. Molecular Therapy-Methods & Clinical Development
- The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma
- (2018) Bianca Simon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell
- (2018) Marco Ruella et al. NATURE MEDICINE
- Tissue-Specific Roles of NKT Cells in Tumor Immunity
- (2018) Masaki Terabe et al. Frontiers in Immunology
- Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
- (2018) Christopher Groth et al. BRITISH JOURNAL OF CANCER
- Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting
- (2018) Antonia Rotolo et al. CANCER CELL
- Universal CARs, universal T cells, and universal CAR T cells
- (2018) Juanjuan Zhao et al. Journal of Hematology & Oncology
- Myeloid suppressor cells in cancer and autoimmunity
- (2017) Antonio Sica et al. JOURNAL OF AUTOIMMUNITY
- Autoreactivity to Sulfatide by Human Invariant NKT Cells
- (2017) Annelein M. Stax et al. JOURNAL OF IMMUNOLOGY
- CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
- (2017) Terry J Fry et al. NATURE MEDICINE
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Synthesis of C6′′-modified α-C-GalCer analogues as mouse and human iNKT cell agonists
- (2017) Joren Guillaume et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- GD2 expression in breast cancer
- (2017) Giulia Orsi et al. Oncotarget
- Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer
- (2017) Venkatrao Vantaku et al. Oncotarget
- Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”
- (2017) Anja Feldmann et al. Oncotarget
- Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer
- (2017) Simon Gebremeskel et al. Cancer Immunology Research
- Reciprocal Crosstalk between Dendritic Cells and Natural Killer T Cells: Mechanisms and Therapeutic Potential
- (2017) Christian W. Keller et al. Frontiers in Immunology
- Natural Killer T Cell-Targeted Immunotherapy Mediating Long-term Memory Responses and Strong Antitumor Activity
- (2017) Nyambayar Dashtsoodol et al. Frontiers in Immunology
- Alpha-Galactosylceramide/CD1d-Antibody Fusion Proteins Redirect Invariant Natural Killer T Cell Immunity to Solid Tumors and Promote Prolonged Therapeutic Responses
- (2017) Lianjun Zhang et al. Frontiers in Immunology
- Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors
- (2017) Martin H. Pedersen et al. OncoImmunology
- Improved Detection of Cytokines Produced by Invariant NKT Cells
- (2017) Duygu Sag et al. Scientific Reports
- Oncolytic Virus-Mediated Targeting of PGE 2 in the Tumor Alters the Immune Status and Sensitizes Established and Resistant Tumors to Immunotherapy
- (2016) Weizhou Hou et al. CANCER CELL
- The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy
- (2016) Martina Ahlmann et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells
- (2016) Toshiko Kamata et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dendritic cell-based immunotherapy
- (2016) Rachel L Sabado et al. CELL RESEARCH
- CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo
- (2016) Gengwen Tian et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficient Regeneration of Human Vα24+Invariant Natural Killer T Cells and Their Anti-Tumor Activity In Vivo
- (2016) Daisuke Yamada et al. STEM CELLS
- CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control
- (2016) Linnea Veinotte et al. OncoImmunology
- The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant Treatment
- (2016) Sebastian Lundgren et al. PLoS One
- Co-Expansion of Cytokine-Induced Killer Cells and Vγ9Vδ2 T Cells for CAR T-Cell Therapy
- (2016) Shou-Hui Du et al. PLoS One
- NF-κB Regulates PD-1 Expression in Macrophages
- (2015) Alexander P. R. Bally et al. JOURNAL OF IMMUNOLOGY
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of iNOS activity enhances the anti-tumor effects of alpha-galactosylceramide in established murine cancer model
- (2015) Hiroyasu Ito et al. Oncotarget
- The Extended Family of CD1d-Restricted NKT Cells: Sifting through a Mixed Bag of TCRs, Antigens, and Functions
- (2015) Elodie Macho-Fernandez et al. Frontiers in Immunology
- Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice
- (2015) Simon Gebremeskel et al. OncoImmunology
- Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy
- (2014) A. Heczey et al. BLOOD
- Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma
- (2014) Licun Wu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeted Delivery of α-Galactosylceramide to CD8α+Dendritic Cells Optimizes Type I NKT Cell–Based Antitumor Responses
- (2014) Elodie Macho-Fernandez et al. JOURNAL OF IMMUNOLOGY
- -Galactosylceramide but Not Phenyl-Glycolipids Induced NKT Cell Anergy and IL-33-Mediated Myeloid-Derived Suppressor Cell Accumulation via Upregulation of egr2/3
- (2014) J.-R. Huang et al. JOURNAL OF IMMUNOLOGY
- Recognition of Lysophosphatidylcholine by Type II NKT Cells and Protection from an Inflammatory Liver Disease
- (2014) Igor Maricic et al. JOURNAL OF IMMUNOLOGY
- Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response
- (2014) J. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination
- (2014) Josianne Nitcheu Tefit et al. VACCINE
- NKT Cell Networks in the Regulation of Tumor Immunity
- (2014) Faith C. Robertson et al. Frontiers in Immunology
- iNKT/CD1d-antitumor immunotherapy significantly increases the efficacy of therapeutic CpG/peptide-based cancer vaccine
- (2014) Stéphanie Corgnac et al. Journal for ImmunoTherapy of Cancer
- Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors
- (2014) By Zhao et al. Journal for ImmunoTherapy of Cancer
- Synergistic Induction of Adaptive Antitumor Immunity by Codelivery of Antigen with α-Galactosylceramide on Exosomes
- (2013) Ulf Gehrmann et al. CANCER RESEARCH
- Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments
- (2013) H Inoue et al. CELL DEATH AND DIFFERENTIATION
- Inactivation of tumor-specific CD8+ CTLs by tumor-infiltrating tolerogenic dendritic cells
- (2013) Hirotomo Harimoto et al. IMMUNOLOGY AND CELL BIOLOGY
- The combination therapy of α-galactosylceramide and 5-fluorouracil showed antitumor effect synergistically against liver tumor in mice
- (2013) Hiroshi Aketa et al. INTERNATIONAL JOURNAL OF CANCER
- Characteristics of Oncolytic Vesicular Stomatitis Virus Displaying Tumor-Targeting Ligands
- (2013) A. Ammayappan et al. JOURNAL OF VIROLOGY
- A Glycolipid Adjuvant, 7DW8-5, Enhances CD8+ T Cell Responses Induced by an Adenovirus-Vectored Malaria Vaccine in Non-Human Primates
- (2013) Neal N. Padte et al. PLoS One
- NKT Cells as an Ideal Anti-Tumor Immunotherapeutic
- (2013) Shin-ichiro Fujii et al. Frontiers in Immunology
- Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines
- (2013) Martin K. Hunn et al. OncoImmunology
- NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma
- (2012) S. R. Mattarollo et al. BLOOD
- Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma
- (2012) J. Richter et al. BLOOD
- Invariant NKT cells increase drug-induced osteosarcoma cell death
- (2012) S Fallarini et al. BRITISH JOURNAL OF PHARMACOLOGY
- CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses
- (2012) Stéphanie Corgnac et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Molecular Identification of GD3 as a Suppressor of the Innate Immune Response in Ovarian Cancer
- (2012) T. J. Webb et al. CANCER RESEARCH
- Myeloid Progenitor Cells in the Premetastatic Lung Promote Metastases by Inducing Mesenchymal to Epithelial Transition
- (2012) D. Gao et al. CANCER RESEARCH
- Sulfatide inhibits -galactosylceramide presentation by dendritic cells
- (2012) M. Kanamori et al. INTERNATIONAL IMMUNOLOGY
- IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity
- (2012) Daofeng Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis
- (2012) Venkata Lokesh Battula et al. JOURNAL OF CLINICAL INVESTIGATION
- Distinct APCs Explain the Cytokine Bias of -Galactosylceramide Variants In Vivo
- (2012) L. Bai et al. JOURNAL OF IMMUNOLOGY
- Role of sulfatide in normal and pathological cells and tissues
- (2012) Tadanobu Takahashi et al. JOURNAL OF LIPID RESEARCH
- Activated iNKT Cells Promote Memory CD8+ T Cell Differentiation during Viral Infection
- (2012) Emma C. Reilly et al. PLoS One
- Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?
- (2012) P. Borst Open Biology
- Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells
- (2012) James E. East et al. Jove-Journal of Visualized Experiments
- Comparison of Clinical and Immunological Effects of Intravenous and Intradermal Administration of -GalactosylCeramide (KRN7000)-Pulsed Dendritic Cells
- (2011) A. J. Nicol et al. CLINICAL CANCER RESEARCH
- NKG2D performs two functions in invariant NKT cells: Direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d
- (2011) Carlotta Kuylenstierna et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles
- (2011) Elodie Macho Fernandez et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- NKT TCR Recognition of CD1d- -C-Galactosylceramide
- (2011) O. Patel et al. JOURNAL OF IMMUNOLOGY
- CD1d-Expressing Breast Cancer Cells Modulate NKT Cell-Mediated Antitumor Immunity in a Murine Model of Breast Cancer Metastasis
- (2011) Laura M. Hix et al. PLoS One
- Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy
- (2010) Kazuki Yamasaki et al. CLINICAL IMMUNOLOGY
- Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans
- (2010) Leonid S. Metelitsa CLINICAL IMMUNOLOGY
- Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells
- (2010) Hiroshi Watarai et al. JOURNAL OF CLINICAL INVESTIGATION
- Co-receptor choice by Vα14iNKT cells is driven by Th-POK expression rather than avoidance of CD8-mediated negative selection
- (2010) Isaac Engel et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Invariant NKT Cells Preferentially Modulate the Function of CD8α + Dendritic Cell Subset in Inducing Type 1 Immunity against Infection
- (2010) Antony George Joyee et al. JOURNAL OF IMMUNOLOGY
- CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
- (2010) B. H. Nelson JOURNAL OF IMMUNOLOGY
- CD1d, a Sentinel Molecule Bridging Innate and Adaptive Immunity, Is Downregulated by the Human Papillomavirus (HPV) E5 Protein: a Possible Mechanism for Immune Evasion by HPV
- (2010) S. Miura et al. JOURNAL OF VIROLOGY
- Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients
- (2010) A C Chan et al. LEUKEMIA
- iNKT Cells Control Mouse Spontaneous Carcinoma Independently of Tumor-Specific Cytotoxic T Cells
- (2010) Matteo Bellone et al. PLoS One
- Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant
- (2010) X. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles
- (2010) Han Hsi Wong et al. Viruses-Basel
- Type I natural killer T cells suppress tumors caused by p53 loss in mice
- (2009) J. B. Swann et al. BLOOD
- Combination therapy ofin vitro-expanded natural killer T cells and α-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma
- (2009) Naoki Kunii et al. CANCER SCIENCE
- Invariant Natural Killer T Cells Regulate Breast Cancer Response to Radiation and CTLA-4 Blockade
- (2009) K. A. Pilones et al. CLINICAL CANCER RESEARCH
- CD152 (CTLA-4) regulates effector functions of CD8+T lymphocytes by repressing Eomesodermin
- (2009) Johannes K. Hegel et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasms
- (2009) D. Bagnara et al. HAEMATOLOGICA
- Identification of C-glycoside analogues that display a potent biological activity against murine and human invariant natural killer T cells
- (2009) Xiangming Li et al. IMMUNOLOGY
- Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
- (2009) Liping Song et al. JOURNAL OF CLINICAL INVESTIGATION
- Mechanism of action of lenalidomide in hematological malignancies
- (2009) Venumadhav Kotla et al. Journal of Hematology & Oncology
- Role of Invariant NK T Lymphocytes in Immune Responses to CpG Oligodeoxynucleotides
- (2009) C. Paget et al. JOURNAL OF IMMUNOLOGY
- CD1d-Based Combination Therapy Eradicates Established Tumors in Mice
- (2009) M. W. L. Teng et al. JOURNAL OF IMMUNOLOGY
- Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted into Immunogenic APCs with the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine
- (2009) H.-J. Ko et al. JOURNAL OF IMMUNOLOGY
- Enhanced Tumor Metastasis in Response to Blockade of the Chemokine Receptor CXCR6 Is Overcome by NKT Cell Activation
- (2009) R. Cullen et al. JOURNAL OF IMMUNOLOGY
- PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells
- (2009) V. V. Parekh et al. JOURNAL OF IMMUNOLOGY
- A Phase I-II Study of -Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer
- (2009) S. Motohashi et al. JOURNAL OF IMMUNOLOGY
- Human prostate-infiltrating CD8+T lymphocytes are oligoclonal and PD-1+
- (2009) Karen S. Sfanos et al. PROSTATE
- Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy
- (2009) Prakash Thapa et al. VACCINE
- Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma
- (2008) G. J. Renukaradhya et al. BLOOD
- B-lymphocyte contributions to human autoimmune disease
- (2008) Koichi Yanaba et al. IMMUNOLOGICAL REVIEWS
- Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand
- (2008) Jun-Eui Park et al. IMMUNOLOGY
- Sustained activation and tumor targeting of NKT cells using a CD1d–anti-HER2–scFv fusion protein induce antitumor effects in mice
- (2008) Kathrin Stirnemann et al. JOURNAL OF CLINICAL INVESTIGATION
- Invariant NKT cells reduce the immunosuppressive activity of influenza A virus–induced myeloid-derived suppressor cells in mice and humans
- (2008) Carmela De Santo et al. JOURNAL OF CLINICAL INVESTIGATION
- Peripheral NKT Cells in Simian Immunodeficiency Virus-Infected Macaques
- (2008) C. S. Fernandez et al. JOURNAL OF VIROLOGY
- Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population
- (2008) J. M. Coquet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started